Porphyria cutanea tarda as rare cutaneous manifestation of hepatic metastases treated with interferon

7Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.
Get full text

Abstract

A 53-year-old woman with blistering on the hands was diagnosed with porphyria cutanea tarda (PCT). At that time, she was treated with interferon for liver metastasis of a pancreas tumor since 7 years. Although apparently rare, PCT has been described as possible cutaneous manifestation both of hepatic tumors and interferon treatment. Further, PCT can also be exacerbated by hepatitis C virus infection, alcohol, estrogens, HFE gene mutations predisposing for hereditary hemochromatosis, hexachlorobenzene, and 2,3,7,8-tetrachlorodibenzo-p -dioxin. Therefore, it is important to keep in mind that the manifestation of PCT may be associated with distinct precipitating factors, which are briefly discussed here. © 2007 The Authors Journal compilation © 2007 The International Society of Dermatology.

Cite

CITATION STYLE

APA

Mosterd, K., Henquet, C., & Frank, J. (2007). Porphyria cutanea tarda as rare cutaneous manifestation of hepatic metastases treated with interferon. International Journal of Dermatology, 46(SUPPL. 3), 19–21. https://doi.org/10.1111/j.1365-4632.2007.03504.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free